Introduction
Peritonitis is an inflammation of the peritoneum that occurs in patients with end-stage renal disease (ESRD) treated by peritoneal dialysis (PD). It typically has an infectious etiology, mainly due to gram-positive bacilli or fungus (1) . Bacterial infections come from contamination during PD and fungal infections may occur subsequent to antibiotic use. Peritonitis is a major complication of PD, with high rate of morbidity and mortality in patients on continuous ambulatory peritoneal dialysis (CAPD). Fungal peritonitis is dreaded complication, accounting for 2%-7% of PD related peritonitis. It should be strongly suspected after recent antibiotic treatment for bacterial peritonitis. Comparatively fungal peritonitis is associated with higher rates of hospitalization, catheter removal, transfer to hemodialysis and death. In recent reports, several other filamentous fungi, yeasts are increasingly being isolated. We report a case of CAPD peritonitis with Curvularia lunata and its management.
Case presentation 45-year-old man, farmer by occupation, presented with ESRD, secondary to diabetic nephropathy. He was on hemodialysis for three months. Subsequently, initiated on CAPD, via Swan neck, Tenckhoff catheter. He was on four exchange/day with ultrafiltration of 1 liter/day and residual urine output 700 ml/day. Patient was stable for 6 months. Later, patient developed abdominal pain and PD fluid of cloudy in color. The analysis of PD fluid, showed, neutrophilic leukocytosis (WBC; 700/µl). He was empirically treated with cefazolin, and vancomycin, intraperitoneally. His symptoms persisted for 2 weeks. At this point, he was referred to Sri Ramachandra medical Centre, Chennai, India, in view of refractory peritonitis. On presentation, patient was febrile and in fluid over load state. Local Examination at catheter site showed skin excoriation purulent discharge, no evidence of tunnel infection. PD catheter had black, flaky material ( Figure 1 ). PD Fluid analysis showed neutrophilic leukocytosis. Potassium hydroxide mount, showed septate, fungal hyphae. Diagnosis of fungal peritonitis was made, he was started on T. ture specimen showed brown conidiophores with 3-4 mm diameter septate hyphae, resulting in diagnosis of Curvularia lunata PD peritonitis. Tip of catheter grew the same organism.
Discussion
Curvularia are facultative soil saprophytes, prevalent in warm and humid areas. Inhalation and skin inoculation being main routes of infection, Curvularia grow rapidly, forming brownish gray to black colonies. CAPD Peritonitis due to fungi Curvularia lunata must be suspected if black flakes are seen in the effluent of catheter (2) . Curvularia species cause disease in humans and animals. Genus Curvularia comprises of several other species (3, 4) . Evidence from International Society for Peritoneal Dialysis (ISPD) guidelines state that species identification and minimum inhibitory concentration (MIC) values are crucial due to the emergence of resistance to azoles (5) . Treatment includes of amphotericin B, voriconazole. Fluconazole prophylaxis effective in patients in preventing secondary fungal infections in patients treated for bacterial peritonitis (3) . Intraperitoneal use of amphotericin causes chemical peritonitis while in use leads to poor peritoneal penetration (6) . Currently our patient is doing well after catheter removal, shifted to maintenance hemodialysis (MHD). Retrospective study done in our center, during seven years period stated that Candida albicans and non-albicans are most prevalent (7) . Curvularia known to cause other extra renal disease like endocarditis, secondary allergic bronchopulmonary aspergillosis and endophthalmitis. In summary, our report shows the management of CAPD associated Curvularia lunata peritonitis.
Conclusion
In ESRD treated by PD, peritonitis is an inflammation with infectious etiology mainly due to gram-positive bacilli or fungus. Fungal peritonitis is associated with higher rates of hospitalization, catheter removal, transfer to hemodialysis and death. Evaluation of the patients who have Curvularia lunata peritonitis can help to rule out other etiologies and helps in the management of CAPD associated Curvularia lunata peritonitis.
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